Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2014 Nov 6;2:2050312114557376. doi: 10.1177/2050312114557376

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2014

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).

PMC Copyright notice

Figure 4. — Efficacy of chemotherapy after HT according to the tumor subtype. (a) Clinical benefit rate of prior HT. (b) Kaplan–Meier curve of the time to HT failure. The tumor response to the first-line chemotherapy regimen in the (c) luminal A cases and (d) non-luminal A cases. (e) Clinical benefit rate of the first-line chemotherapy regimen. The tumor response for all chemotherapy regimens in the (f) luminal A cases and (g) non-luminal A cases. (h) Clinical benefit rate for all chemotherapy regimens. (i) Kaplan–Meier curve of the time to chemotherapy failure.

MST: median survival time; CR: complete response; PR: partial response; SD: stable disease; PD: progressive disease; HT: hormone therapy.